Dr Reddys Laboratories Share Price Today - Live Blog for May 28, 2025

With a -0.34% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,240.10. The stock is currently trading at a PE of 18.3500, while the industry PE is 33.8779, prompting investors to assess its value proposition.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.11% gain, with the share price now at ₹1,244.35. Notably, the stock's PE ratio stands at 18.3500, and its Return on Equity (ROE) is 16.8559%.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.19%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,243.50 per share.

Demonstrating a commendable 0.02% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,240.25. In terms of valuation, the stock maintains a PE ratio of 18.3500, while the industry PE ratio stands at 33.8779.

Dr Reddys Laboratories Ltd experienced a -0.03% downturn in its share price, and it's currently trading at ₹1,240.00. This situation is generating interest among value investors who are evaluating the stock's potential.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.05%, reaching the current market price of ₹1,240.05. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd witnessed a notable 0.04% surge in its share price and is presently trading at ₹1,239.00, captivating the attention of market participants.

With a remarkable 0.00% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,239.00. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3500, while the industry's PE ratio is 33.8779.

Dr Reddys Laboratories Ltd showed no price shifts, holding steady at ₹1,238.60. While the stock's performance remains consistent, it's worth noting that its PE ratio is 18.3500, while the industry PE is 33.8779.

The stock of Dr Reddys Laboratories Ltd suffered a -0.06% drop, and it's now trading at ₹1,238.15 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd witnessed a -0.21% decrease in its share price, and it is currently trading at ₹1,238.25. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 0.10% increase. Presently, it is actively trading at ₹1,241.45.

With a -0.02% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,240.35. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3500, whereas the industry PE ratio stands at 33.8779.

Dr Reddys Laboratories Ltd's stock price surged by 0.11%, reaching the current market value of ₹1,240.65 per share. This surge is a testament to the stock's recent performance.

With a -0.13% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,240.00. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.3500, while the industry PE is 33.8779.

In recent times, Dr Reddys Laboratories Ltd witnessed a decline of -0.12% in its share price, and it currently trades at ₹1,241.90 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.03% upswing, and it's currently trading at ₹1,243.45 per share. Investors are closely watching this development.

After a -0.16% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,242.95. The stock has a PE ratio of 18.3500, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd experienced a -0.22% downturn in its share price, and it's currently trading at ₹1,244.25. This situation is generating interest among value investors who are evaluating the stock's potential.

Dr Reddys Laboratories Ltd's share price remained flat, currently at ₹1,246.50. This sustained performance provides investors with an opportunity to assess whether the stock aligns with their investment objectives.

Dr Reddys Laboratories Ltd share price has declined by -0.07%, and it's currently trading at ₹1,244.40. The stock maintains a PE of 18.3500, while the industry PE is 33.8779, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd observed a remarkable 0.02% surge in its share price and is presently trading at ₹1,245.00. The increased investor interest is driving this surge.

With a -0.14% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,244.50. The stock is currently trading at a PE of 18.3500, while the industry PE is 33.8779, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd witnessed a -0.18% drop in its share price and is currently trading at ₹1,246.65. With the stock's PE at 18.3500 and the industry PE at 33.8779, investors are weighing their options.

Dr Reddys Laboratories Ltd's stock price surged by 0.16%, reaching the current market value of ₹1,248.85 per share. This surge is a testament to the stock's recent performance.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.15% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,246.90 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.